Cannapharmarx (CPMD) Stock Statistics & Valuation Metrics

Cannapharmarx has a market cap or net worth of $1.99M. The enterprise value is $20.04M.

Cannapharmarx has 662,501,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cannapharmarx’s return on equity (ROE) is 0.50 and return on invested capital (ROIC) is 62.72%.

The current PE Ratio of Cannapharmarx is 5.9. Cannapharmarx’s PEG ratio is ―.

In the last 12 months, Cannapharmarx had revenue of 820.14K and earned -9.91M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -1.77M and capital expenditures 0.00, giving a free cash flow of -1.77M billion.

Cannapharmarx pays an annual dividend of ―, resulting in a dividend yield of ―

Cannapharmarx upcoming earnings date is ―, ―.

Cannapharmarx as a current ratio of 0.04, with Debt / Equity ratio of -78.95%

In the past 12 months, Cannapharmarx has paid 0.00 in taxes.

Cannapharmarx EV to EBITDA ratio is -2.50, with an EV/FCF ratio of -11.27.

Cannapharmarx has $16.98K in cash and marketable securities with $17.82M in debt, giving a net cash position of -$17.80M billion.

Gross margin is -232.97%, with operating margin of -439.68%, and net profit margin of -1207.85%.

The average price target for Cannapharmarx is ―, which is 11.43% higher than the current price. The consensus rating is ―